Methotrexate eluting stents: to modify or cure?

Heart. 2004 Feb;90(2):121-2. doi: 10.1136/hrt.2003.019638.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Coronary Restenosis / drug therapy*
  • Equipment Failure
  • Folic Acid Antagonists / administration & dosage*
  • Humans
  • Methotrexate / administration & dosage*
  • Models, Animal
  • Models, Biological
  • Stents*

Substances

  • Folic Acid Antagonists
  • Methotrexate